Browse 1,565 thyroid cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Most thyroid cancers grow slowly and have some of the best outcomes of any cancer, which is why some small ones can now be safely monitored instead of removed right away. A small share behave very differently: cancers that stop responding to radioactive iodine, inherited medullary thyroid cancer, and the rare but aggressive anaplastic type. Targeted medicines matched to specific gene changes have opened new options for these groups.
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
for
Head and Neck Cancer
Location: New York NY, Kansas City KS
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT06030011
Recruiting
Patient Derived Preclinical Models
for
Cancer
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05324553
Recruiting
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
for
Colorectal Cancer, Metastatic Cancer
Location: Goshen IN
Sponsor: Goshen Health System
Sex: All
Age: 18+
Code: NCT00408551
Phase 2, Recruiting
The Radiation Oncology Registry and Biosample Repository
for
Neoplasia
Location: Voorhees Township NJ, Philadelphia PA, Lancaster PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT01577251
Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
A Motion Exergaming Approach for Symptom Management: HNC
for
Head and Neck Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04632654
Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: Mineola NY, New York NY, Sarasota FL, Portland OR,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05867251
Phase 1, Phase 2, Recruiting
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
for
Solid Tumor
Location: Dallas TX
Sponsor: Abbisko Therapeutics Co, Ltd
Sex: All
Age: 18+
Code: NCT05244551
Phase 1, Recruiting
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
for
Colorectal Cancer, Pancreatic Cancer,
Location: Boston MA, Fairfax VA, San Antonio TX,
Sponsor: PAQ Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07300150
Phase 1, Recruiting
IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment
for
Pediatric Cancer, Pediatric Hematology
Location: Edmonton, Calgary
Sponsor: University of Calgary
Sex: All
Age: 5 - 18
Code: NCT04956133
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Colorectal Cancer
Location: New Brunswick NJ, Toronto, Atlanta GA, Ann Arbor MI,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06004245
Phase 1, Recruiting
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer